CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in CalciMedica, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- −27 vs. Q4 2022
- Shares held
- 0
- −11.9M (−100.0%) vs. Q4 2022
- Total value
- $0
- −$5.97M (−100.0%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 27
- 0 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −5,281,713−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −4,163,347−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −1,235,943−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −419,923−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −271,332−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −156,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −100,226−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −66,214−100.0% | Sold out |
| Johnson & Johnson | 0 | $0 | 0.00% | −49,547−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −44,860−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −41,900−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −35,073−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −16,104−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −13,410−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −10,866−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −8,612−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,376−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,379−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −642−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −631−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |